All Blog Posts


Interview with a scientist: proteomics, biomarkers and ALS.

No effective therapies are currently available for Amyotrophic Lateral Sclerosis due to the lack of biomarkers for early diagnosis and monitoring disease progression. Meet here, Dr. Valentina Bonetto, and read about her research efforts based on proteomic assays to find validated biomarkers and innovative therapeutic strategies